he RNA at the Bench and Bedside IV conference, organized by the prestigious Nature journal series, will be held from December 9–11, 2024, in San Diego, USA. This invitation-only high-level academic meeting gathers leading global experts and scholars in the field of nucleic acid therapeutics to discuss the latest research advances, clinical outcomes, and future challenges. Participants will engage in in-depth discussions on RNA and DNA biology, preclinical therapeutic studies, clinical translation of gene therapies, and innovative applications of emerging technologies, aiming to foster international collaboration and drive continued innovation in the nucleic acid therapeutics field.
As a global leader in AI + drug delivery and the only invited Chinese company representative, Dr. Anton Liu, Vice President and Head of Technology Platforms at METiS Technologies, will present on December 11 (Wednesday) from 11:00–11:25 during SESSION VII: Nucleic Acid Delivery. His talk, titled “Extra-hepatotropic LNP Discovery Empowered by AI”, will highlight METiS Technologies’ world-leading achievements in extra-hepatic targeted lipid nanoparticle (LNP) delivery. The session will also feature presentations by LNP pioneer Professor Pieter Cullis and emerging LNP expert Professor Daniel Siegwart.
